Clinical trials
Completed Observational Pancreatic Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
281 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2002 | 4 |
| 2003 | 2 |
| 2004 | 8 |
| 2005 | 6 |
| 2006 | 9 |
| 2007 | 12 |
| 2008 | 16 |
| 2009 | 9 |
| 2010 | 9 |
| 2011 | 6 |
| 2012 | 11 |
| 2013 | 14 |
| 2014 | 19 |
| 2015 | 13 |
| 2016 | 12 |
| 2017 | 14 |
| 2018 | 16 |
| 2019 | 21 |
| 2020 | 18 |
| 2021 | 24 |
| 2022 | 16 |
| 2023 | 6 |
| 2024 | 2 |
| 2025 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 281 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mayo Clinic | 8 |
| Peking Union Medical College Hospital | 5 |
| Rigshospitalet, Denmark | 5 |
| Clinical Hospital Colentina | 4 |
| Columbia University | 4 |
| Johns Hopkins University | 4 |
| Memorial Sloan Kettering Cancer Center | 4 |
| Seoul National University Hospital | 4 |
| Wake Forest University Health Sciences | 4 |
| AstraZeneca | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pancreatic Neoplasms | 281 |
| Stomach Neoplasms | 35 |
| Colorectal Neoplasms | 33 |
| Lung Neoplasms | 27 |
| Breast Neoplasms | 25 |
| Esophageal Neoplasms | 24 |
| Liver Neoplasms | 21 |
| Colonic Neoplasms | 20 |
| Neoplasms | 19 |
| Ovarian Neoplasms | 17 |
Trials
Showing 1 to 25 of 281. Each trial links to its page on Pharma Observatory.
181 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.